Marlio Charles Mosseri, 10% Owner at Nuvectis Pharma, Inc. (NVCT), bought 81,242 shares at $4.70 ($378K) on 2024-12-13, disclosed to the SEC on 2024-12-16.
Open-market purchase of $378k NVCT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.64 | 32,121 | $149K | 39.4% |
| 2 | $4.64 | 32,121 | $149K | 39.4% |
| 3 | $4.70 | 17,000 | $80K | 21.1% |
| Total | $4.65 avg | 81,242 | $378K | 100% |
| Filing → |
| NVCT | BUY | 2025-06-24 | $45K | — | Filing → |
| NVCT | BUY | 2025-06-20 | $495K | — | Filing → |
| NVCT | BUY | 2025-05-13 | $343K | — | Filing → |